Recently visited unit
name Price (yuan) Rise and fall
The following are popular stocks
Please check the self selected shares first
join remind View in APP

Renhe Pharmaceutical (000650.SZ)

Questioning stocks
@change@
@changeP@
@now@
Limit: @ up_limit@
Limit: @ down_limit@
Suspension
@date@ @time@
Temporary suspension
Today: @open@ Volume: @volume@ Amplitude: @swing@
Maximum: @high@ Turnover: @amount@ turnover rate: @turnover@
Minimum: @low@ Total Market Value: @fixTotalShare@ P/B ratio: @pb@
Received yesterday: @preClose@ Circulation value: @cvs@ P/E ratio TTM @pe@
Total share capital: @zgb@ Circulating shares: @ltgb@
Information mine:
    The browser version is too low to view the multi null inversion

    Your browser version is too low to view empty data. It is recommended to use IE10 (including) above Firefox Google

    Time-sharing
    Day K
    Week K
    Month K
    K line
    Reinstatement K line
    Technical drawings
    Also concerned:
      5th gear disc opening
      Live broadcast of famous teachers
      Commission ratio -- Abandonment --
      Selling ⑤ -- --
      Sell ④ -- --
      Selling ③ -- --
      Sell ② -- --
      Selling ① -- --
      deal --
      Buy ① -- --
      Buy ② -- --
      Buy ③ -- --
      Buy ④ -- --
      Buy ⑤ -- --
      Outer disc -- Inner disc --

      In case of a key big order, the main force may**

      Quickly use level2 to view details>
      time Price (yuan) Measurement (hand) nature
      time Price (yuan) Measurement (hand) nature
      Transaction price (yuan) Trading volume (hand) Proportion (%)
      time Transaction price (yuan) Trading volume (hand)
      Product entry: Sina Finance APP - Stocks - Investment Research Report
      Product entrance: Sina Finance APP - stock - free question
      Product entrance: Sina Finance APP - stock - free question
      Main and retail investors' capital flow
      Main buy Main sales Purchase by retail investors Retail sales
      Amount (10000 yuan) @mainIn@ @mainOut@ @retailIn@ @retailOut@
      proportion @mainInP@ @mainOutP@ @retailInP@ @retailOutP@
      Loose bill
      Small order
      Large order
      Extra large order
      Net inflow of classified funds
      Loose bill Small order Large order Extra large order
      Net inflow (10000 yuan) @r3_r_in@ @r2_r_in@ @r1_r_in@ @r0_r_in@
      Proportion in the flow board @r3_p_svs@ @r2_p_svs@ @r1_p_svs@ @r0_p_svs@
      Proportion in turnover rate @r3_p_turnover@ @r2_p_turnover@ @r1_p_turnover@ @r0_p_turnover@
      title click reply Final reply

      Company research

      Hot data

      more
      Adjacent ranking
      Top 10 in the industry

      Financial ratios

      more
      Adjacent ranking
      Top 10 in the industry

      Investment rating of research institutions

      more

      In the last 60 days Renhe Pharmaceutical (sz000650) rating was released in three research reports, and the comprehensive rating is as follows:

      Hot columns

      Industry comparison

      name Price (yuan)

      corporate name:

      RENHE PHARMACY co., ltd

      Main business:

      Production and sales of Chinese and Western medicines, APIs and health related products, including oral solid preparations, oral

      Telephone: 0791-83896755

      Fax: 0791-83896755

      Date of establishment: 1996-12-04

      Listing date: 1996-12-10

      Legal representative: Yang Xiao

      general manager: Huang Wujun

      Registered capital: 1399.94 million yuan

      Issue price: 6.26 yuan

      Latest total share capital: 1399938234 shares

      Latest outstanding shares: 1331385834 shares

      Segment: Shanghai and Shenzhen A-share Manufacturing index Shenzhen A-share Pharmaceutical index Shenzhen Composite Index Equity incentive Pharmaceuticals Shenzhen Stock Connect Shenzhen Stock Connect Pharmaceutical Biology Traditional Chinese Medicine II Pharmaceutical Biology

      2024-03
      2023-12
      2023-09
      2023-06
      2023-03
      Earnings per share 0.1266 yuan RMB 0.4052 0.3860 yuan 0.2547 yuan 0.1302 yuan
      net asset value per share 4.3791 yuan 4.2809 yuan 4.2867 yuan 4.1554 yuan 4.2310 yuan
      Net operating cash flow per share 0.0805 yuan 0.3568 yuan 0.1506 yuan 0.0786 yuan -0.1041 yuan
      Return on net assets 2.89% 9.47% 9% 6.13% 3.08%
      Undistributed profit per share 2.5493 yuan 2.4227 yuan 2.4304 yuan 2.2990 yuan 2.3746 yuan
      Capital reserve per share RMB 0.5792 RMB 0.5792 0.5613 yuan 0.5613 yuan 0.5613 yuan
      Date of announcement Allocation scheme
      2023-06-01 10 pairs, 2 yuan
      2022-05-20 10 pairs1 yuan
      2021-05-22 10 pairs, 2 yuan
      2020-05-23 10 pairs1 yuan
      2019-06-04 10 pairs1 yuan
      2024-03
      2023-12
      2023-12
      Name of shareholders Shareholding (%) Increase or decrease
      Renhe (Group) Co., Ltd twenty-four point four three three Unchanged
      Yang Xiao one point seven one six Unchanged
      HKSCC has one point two two three reduce one's shares in a listed company
      Industrial and Commercial Bank of China shares one point zero three one New progress
      Bank of China shares have zero point nine seven eight New progress
      Industrial and Commercial Bank of China zero point six nine eight New progress
      Basic endowment insurance base zero point six two zero New progress
      Industrial and Commercial Bank of China shares zero point five nine one reduce one's shares in a listed company
      Wang Caiyong zero point five five eight Unchanged
      National Social Security Fund I zero point five two seven Unchanged

      Shareholding ratio of circulating shareholders



      user name:
      Password: